Ocugen (OCGN) Net Margin (2014 - 2026)
Ocugen's (OCGN) quarterly Net Margin came in at 1250.95% in Q1 2026, down 21448.0% YoY from N/an in Q1 2025, and down 20.69% on a QoQ basis from 1036.46% in Q1 2025.
Powered by 
Analysis
Ocugen (OCGN) Net Margin (2014 - 2026) Analysis & Trends
Ocugen (OCGN) has 7 years of Net Margin data on file, last reported at 1250.95% in Q1 2026.
- Quarterly Net Margin fell 21448.0% year-over-year to 1250.95% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 429.5% (down 74887.0% YoY) and the FY2024 annual result came in at 1.09%, up 104394.0% from the prior year.
- Net Margin declined to 1250.95% in Q1 2026, from 1036.46% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 5246.6% in Q4 2024 to a low of 6699.6% in Q1 2022.
- A 5-year average of 2564.39% and a median of 3359.15% in 2022 frame the typical range for Net Margin.
- Annual changes were most pronounced in 2023 — Net Margin tumbled 198089 bps — and 2024, when it surged 972339 bps.
- Tracing OCGN's Net Margin over 5 years: stood at 2495.9% in 2022, then slumped by 79 bps to 4476.79% in 2023, then jumped by 217 bps to 5246.6% in 2024, then slumped by 120 bps to 1036.46% in 2025, then declined by 21 bps to 1250.95% in 2026.
- The last three Net Margin figures came in at 1250.95% (Q1 2026), 1036.46% (Q1 2025), and 5246.6% (Q4 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 32.99% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 30.23% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 31.16% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -539.31% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 13.90% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 12.74% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 12.09% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -3.12% |
| 10 | Ocugen | 458.91 Mn | 358.81 Mn | - | -1,671.84% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,671.84% |
| Mar 31, 2026 | -1,250.95% |
| Dec 31, 2025 | 9,174.09% |
| Sep 30, 2025 | -1,144.46% |
| Jun 30, 2025 | -1,073.49% |
| Mar 31, 2025 | -1,036.46% |
| Dec 31, 2024 | -1,817.02% |
| Sep 30, 2024 | -1,141.73% |
| Jun 30, 2024 | -902.02% |
| Mar 31, 2024 | -1,175.94% |
| Dec 31, 2023 | -778.57% |
| Sep 30, 2023 | -316.76% |
| Jun 30, 2023 | -4,755.67% |
| Mar 31, 2023 | -4,071.11% |
| Dec 31, 2022 | -2,495.90% |
| Sep 30, 2022 | -4,704.29% |
| Jun 30, 2022 | -3,355.52% |
| Mar 31, 2022 | -3,806.00% |
| Jun 30, 2020 | -37,581.40% |
| Sep 30, 2014 | -1.20% |